HBA1c and Diagnosis of Type 2 Diabetes

Following the 6th Tromso study subjects with HbA1c > 5.7 plus a subsample of subjects with lower hba1c values will be invited to an oral glucose tolerance test to see the predictive value of HBA1c in the diagnosis of type 2 diabetes.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Type 2 Diabetes Diabetes Mellitus Diabetes Mellitus, Type 2 Disease Endocrine System Diseases Glucose Metabolism Disorders Metabolic Diseases Nutritional and Metabolic Diseases Pathologic Processes Pathological Conditions, Signs and Symptoms

Age range

20 year–80 year

Sex eligibility

All sexes

Study type

Observational

Primary location

University Hospital of North Norway

Tromsø, 9038, Norway

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

participated in the 6 Tromso study

Exclusion criteria

type 2 diabetes

Treatment and study plan

Primary outcomes

Number of subjects with new diagnosis of type 2 diabetes

Time frame: Up to 2 years after participation in the 6th Tromso study

Secondary outcomes

Number of subjects with new diagnosis of impaired glucose tolerance

Time frame: Up to 2 years after participation in the 6th Tromso study
Number of subjects with new diagnosis of impaired fasting glucose

Time frame: Up to 2 years after participation in the 6th Tromso study
Effect of vitamin D status on glucose tolerance

Time frame: Up to 2 years after participation in the 6th Tromso study

Sponsors and collaborators

Lead sponsor

University of Tromso

Other

Registry information

Important dates

Study start: 2008
Primary completion: 2010
Study completion: 2010
First posted: Aug 19, 2010
Registry last updated: Jul 20, 2011

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed